Yarbrough Capital’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-2,109
Closed -$447K 211
2023
Q3
$447K Sell
2,109
-2,417
-53% -$483K 0.03% 127
2023
Q2
$871K Hold
4,526
0.05% 100
2023
Q1
$916K Buy
4,526
+2,109
+87% +$338K 0.07% 93
2022
Q4
$311K Hold
2,417
0.02% 142
2022
Q3
$331K Hold
2,417
0.03% 146
2022
Q2
$428K Sell
2,417
-503
-17% -$72.5K 0.03% 118
2022
Q1
$421K Buy
2,920
+503
+21% +$68.1K 0.02% 157
2021
Q4
$374K Buy
+2,417
New +$405K 0.02% 165

Other funds holding SGEN

Yarbrough Capital's SGEN Position: Q4 2023 in Review

Yarbrough Capital sold out of Seagen Inc. Common Stock (SGEN) in Q4 2023, closing a stake of 2,109 shares — an estimated $447K sold.

Yarbrough Capital first reported a position in SGEN in Q4 2021 and held it in 8 quarters. The position peaked at $916K in Q1 2023. 6 funds tracked by Wall St. Rank hold SGEN as of Q4 2023.

  • Yarbrough Capital reported no remaining Seagen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Yarbrough Capital sold 2,109 Seagen Inc. Common Stock shares in Q4 2023, an estimated $447K.
  • Yarbrough Capital first reported a position in Seagen Inc. Common Stock in Q4 2021 and held it in 8 quarters.
  • Yarbrough Capital's Seagen Inc. Common Stock position peaked at $916K in Q1 2023.
  • 6 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2023.

Based on Yarbrough Capital's 13F filing for Q4 2023, filed 12 Jan 2024.